Efficacy of Danshen Class Injection in the Treatment of Acute Cerebral Infarction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Table 3

Results of the network meta-analysis of the whole blood low shear viscosity (lower left quarter) and plasma viscosity (upper right quarter).

A	-0.34; (-0.67, -0.02)	-0.01; (-0.38, 0.36)	-0.53; (-0.79, -0.25)	-0.38; (-0.95, 0.2)	-	-0.15; (-0.54, 0.23)	-
-1.72; (-6.44, 2.96)	B	0.33; (-0.1, 0.77)	-0.19; (-0.52, 0.15)	-0.04; (-0.61, 0.54)	-	0.19; (-0.31, 0.69)	-
-0.09; (-4.73, 4.53)	1.63; (-4.52, 7.82)	C	-0.52; (-0.81, -0.23)	-0.37; (-1.03, 0.29)	-	-0.14; (-0.68, 0.39)	-
-1.33; (-4.91, 2.24)	0.39; (-4.94, 5.74)	-1.24; (-4.71, 2.27)	D	0.15; (-0.46, 0.75)	-	0.37; (-0.1, 0.85)	-
-1.26; (-11.51, 9.03)	0.46; (-10.67, 11.54)	-1.16; (-10.34, 7.99)	0.08; (-9.83, 9.94)	E	-	0.22; (-0.46, 0.91)	-
-19.89; (-26.42, -13.4)	-18.17; (-26.23, -10.16)	-19.79; (-27.82, -11.77)	-18.55; (-25.93, -11.24)	-18.63; (-30.79, -6.51)	F	-	-
-1.33; (-5.99, 3.3)	0.39; (-6.31, 6.93)	-1.24; (-7.72, 5.4)	0; (-5.83, 5.86)	-0.08; (-11.28, 11.1)	18.55; (10.54, 26.64)	G	-
-0.59; (-9.67, 8.64)	1.13; (-9.13, 11.34)	-0.49; (-10.73, 9.79)	0.75; (-9.08, 10.55)	0.67; (-13.1, 14.53)	19.3; (8.18, 30.54)	0.75; (-9.4, 11.15)	H

A: WM; B: Danshen injection + WM; C: Fufang Danshen injection + WM; D: Danhong injection + WM; E: Danshenchuanxiongqin injection + WM; F: Sodium Tanshinone IIA Sulfonate injection + WM; G: Salvianolate injection + WM; H: Danshen Salvianolic Acids injection + WM. The result underlined meant it had statistical significant.